Trials / Completed
CompletedNCT02020902
Post Marketing Surveillance for Contac Bien Z in Japan
Contac Bien Z Adverse Effect Survey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,552 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 15 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a post-marketing surveillance study on a marketed cetrizine hydrochloride formulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cetrizine hydrochloride | As provided on the patient information leaflet |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2013-12-25
- Last updated
- 2016-05-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02020902. Inclusion in this directory is not an endorsement.